ReP USP - Resultado da busca

Artigo de periodico
Relationship between SLCO1B(3) and ABCA(3) polymorphisms and imatinib response in chronic myeloid leukemia patients (2015)
Lima, Luciene Terezina de; Bueno, Carolina Tosin; Vivona, Douglas; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hungria, Vania Tietsche de Moraes; Chiattone, Carlos Sérgio; Zanichelli, Maria Aparecida; Chauffaille, Maria de Lourdes Lopes Ferrari; Guerra-Shinohara, Elvira Maria
Fonte: Hematology. Unidade: FCF
Assuntos: LEUCEMIA MIELOIDE, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Luciene Terezina de et al. Relationship between SLCO1B(3) and ABCA(3) polymorphisms and imatinib response in chronic myeloid leukemia patients. Hematology, v. 20, n. 3, p. 137-142, 2015Tradução . . Disponível em: https://doi.org/10.1179/1607845414Y.0000000181. Acesso em: 18 nov. 2024.
APA
Lima, L. T. de, Bueno, C. T., Vivona, D., Hirata, R. D. C., Hirata, M. H., Hungria, V. T. de M., et al. (2015). Relationship between SLCO1B(3) and ABCA(3) polymorphisms and imatinib response in chronic myeloid leukemia patients. Hematology, 20( 3), 137-142. doi:10.1179/1607845414Y.0000000181
NLM
Lima LT de, Bueno CT, Vivona D, Hirata RDC, Hirata MH, Hungria VT de M, Chiattone CS, Zanichelli MA, Chauffaille M de LLF, Guerra-Shinohara EM. Relationship between SLCO1B(3) and ABCA(3) polymorphisms and imatinib response in chronic myeloid leukemia patients [Internet]. Hematology. 2015 ; 20( 3): 137-142.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1179/1607845414Y.0000000181
Vancouver
Lima LT de, Bueno CT, Vivona D, Hirata RDC, Hirata MH, Hungria VT de M, Chiattone CS, Zanichelli MA, Chauffaille M de LLF, Guerra-Shinohara EM. Relationship between SLCO1B(3) and ABCA(3) polymorphisms and imatinib response in chronic myeloid leukemia patients [Internet]. Hematology. 2015 ; 20( 3): 137-142.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1179/1607845414Y.0000000181
Tese (Doutorado)
Estudo da expressão dos genes ABCB1 e SLC22A1 e sua relação com marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica (2014)
Vivona, Douglas; Guerra-Shinohara, Elvira Maria (Orientador)
Unidade: FCF
Assuntos: LEUCEMIA MIELOIDE, HEMATOLOGIA, POLIMORFISMO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas. Estudo da expressão dos genes ABCB1 e SLC22A1 e sua relação com marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica. 2014. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2014. Disponível em: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-18032014-131945/. Acesso em: 18 nov. 2024.
APA
Vivona, D. (2014). Estudo da expressão dos genes ABCB1 e SLC22A1 e sua relação com marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica (Tese (Doutorado). Universidade de São Paulo, São Paulo. Recuperado de http://www.teses.usp.br/teses/disponiveis/9/9136/tde-18032014-131945/
NLM
Vivona D. Estudo da expressão dos genes ABCB1 e SLC22A1 e sua relação com marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica [Internet]. 2014 ;[citado 2024 nov. 18 ] Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-18032014-131945/
Vancouver
Vivona D. Estudo da expressão dos genes ABCB1 e SLC22A1 e sua relação com marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica [Internet]. 2014 ;[citado 2024 nov. 18 ] Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-18032014-131945/
Artigo de periodico
ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib (2014)
Vivona, Douglas; Lima, Luciene Terezin; Rodrigues, Alice Cristina ; Bueno, Carolina Tosin; Alcantara, Greyce Kelly Steinhorst; Barros, Luiza Saldanha Ribeiro; Hungria, Vania Tietsche de Moraes; Chiattone, Carlos Sérgio; Chauffaille, Maria de Lourdes Lopes Ferrari; Guerra-Shinohara, Elvira Maria
Fonte: Oncology Letters. Unidades: ICB, FCF
Assuntos: LEUCEMIA MIELOIDE, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib. Oncology Letters, v. 7, n. 4, p. 1313-1319, 2014Tradução . . Disponível em: https://doi.org/10.3892/ol.2014.1857. Acesso em: 18 nov. 2024.
APA
Vivona, D., Lima, L. T., Rodrigues, A. C., Bueno, C. T., Alcantara, G. K. S., Barros, L. S. R., et al. (2014). ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib. Oncology Letters, 7( 4), 1313-1319. doi:10.3892/ol.2014.1857
NLM
Vivona D, Lima LT, Rodrigues AC, Bueno CT, Alcantara GKS, Barros LSR, Hungria VT de M, Chiattone CS, Chauffaille M de LLF, Guerra-Shinohara EM. ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib [Internet]. Oncology Letters. 2014 ; 7( 4): 1313-1319.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3892/ol.2014.1857
Vancouver
Vivona D, Lima LT, Rodrigues AC, Bueno CT, Alcantara GKS, Barros LSR, Hungria VT de M, Chiattone CS, Chauffaille M de LLF, Guerra-Shinohara EM. ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib [Internet]. Oncology Letters. 2014 ; 7( 4): 1313-1319.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3892/ol.2014.1857
Artigo de periodico
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia (2014)
Lima, Luciene Terezinha de; Vivona, Douglas; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Castro, Fabíola Attié de; Chauffaille, Maria de Lourdes L. F; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Hungria, Vania Tietsche de Moraes; Guerra-Shinohara, Elvira Maria
Fonte: Medical Oncology. Unidades: FCF, FCFRP
Assuntos: LEUCEMIA MIELOIDE, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Luciene Terezinha de et al. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical Oncology, v. 31, p. 1-11, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12032-014-0851-5. Acesso em: 18 nov. 2024.
APA
Lima, L. T. de, Vivona, D., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2014). Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical Oncology, 31, 1-11. doi:10.1007/s12032-014-0851-5
NLM
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Castro FA de, Chauffaille M de LLF, Zanichelli MA, Chiattone CS, Hungria VT de M, Guerra-Shinohara EM. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia [Internet]. Medical Oncology. 2014 ; 31 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12032-014-0851-5
Vancouver
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Castro FA de, Chauffaille M de LLF, Zanichelli MA, Chiattone CS, Hungria VT de M, Guerra-Shinohara EM. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia [Internet]. Medical Oncology. 2014 ; 31 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s12032-014-0851-5
Trabalho de evento-resumo
ABCG2 and ABCA3 polymorphisms are associated with complete molecular response to Imatinib in chronic myeloid leukemia patients (2013)
Guerra-Shinohara, Elvira Maria ; Bueno, C. T; Vivona, Douglas; Lima, L.T
Fonte: Resumos. Nome do evento: Simpósio Internacional de Iniciação Científica da Universidade de São Paulo - SIICUSP. Unidade: FCF
Assuntos: POLIMORFISMO, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA-SHINOHARA, Elvira Maria et al. ABCG2 and ABCA3 polymorphisms are associated with complete molecular response to Imatinib in chronic myeloid leukemia patients. 2013, Anais.. São Paulo: USP/Pró-Reitoria de Pesquisa, 2013. Disponível em: https://uspdigital.usp.br/siicusp/cdOnlineTrabalhoVisualizarResumo?numeroInscricaoTrabalho=555&numeroEdicao=21. Acesso em: 18 nov. 2024.
APA
Guerra-Shinohara, E. M., Bueno, C. T., Vivona, D., & Lima, L. T. (2013). ABCG2 and ABCA3 polymorphisms are associated with complete molecular response to Imatinib in chronic myeloid leukemia patients. In Resumos. São Paulo: USP/Pró-Reitoria de Pesquisa. Recuperado de https://uspdigital.usp.br/siicusp/cdOnlineTrabalhoVisualizarResumo?numeroInscricaoTrabalho=555&numeroEdicao=21
NLM
Guerra-Shinohara EM, Bueno CT, Vivona D, Lima LT. ABCG2 and ABCA3 polymorphisms are associated with complete molecular response to Imatinib in chronic myeloid leukemia patients [Internet]. Resumos. 2013 ;[citado 2024 nov. 18 ] Available from: https://uspdigital.usp.br/siicusp/cdOnlineTrabalhoVisualizarResumo?numeroInscricaoTrabalho=555&numeroEdicao=21
Vancouver
Guerra-Shinohara EM, Bueno CT, Vivona D, Lima LT. ABCG2 and ABCA3 polymorphisms are associated with complete molecular response to Imatinib in chronic myeloid leukemia patients [Internet]. Resumos. 2013 ;[citado 2024 nov. 18 ] Available from: https://uspdigital.usp.br/siicusp/cdOnlineTrabalhoVisualizarResumo?numeroInscricaoTrabalho=555&numeroEdicao=21
Trabalho de evento-resumo periodico
ABCB1 Haplotypes are associated with lower P-Gp activity and major molecular plasma levels in chronic myeloid leukemia patients (2013)
Vivona, Douglas; Lima, Luciene Terezinha de; Rodrigues, Alice Cristina ; Bueno, Carolina Tosin; Gaitani, Cristiane Masetto de; Chiattone, Carlos Sérgio; Hungria, Vania T; Chauffaille, Maria de Lourdes Lopes Ferrari; Guerra-Shinohara, Elvira Maria
Fonte: Blood. Nome do evento: Annual Meeting and Exposition of the American Society of Hematology. Unidades: ICB, FCFRP, FCF
Assunto: LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCB1 Haplotypes are associated with lower P-Gp activity and major molecular plasma levels in chronic myeloid leukemia patients. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2013
APA
Vivona, D., Lima, L. T. de, Rodrigues, A. C., Bueno, C. T., Gaitani, C. M. de, Chiattone, C. S., et al. (2013). ABCB1 Haplotypes are associated with lower P-Gp activity and major molecular plasma levels in chronic myeloid leukemia patients. Blood. Washington: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Vivona D, Lima LT de, Rodrigues AC, Bueno CT, Gaitani CM de, Chiattone CS, Hungria VT, Chauffaille M de LLF, Guerra-Shinohara EM. ABCB1 Haplotypes are associated with lower P-Gp activity and major molecular plasma levels in chronic myeloid leukemia patients. Blood. 2013 ; 122( 21):[citado 2024 nov. 18 ]
Vancouver
Vivona D, Lima LT de, Rodrigues AC, Bueno CT, Gaitani CM de, Chiattone CS, Hungria VT, Chauffaille M de LLF, Guerra-Shinohara EM. ABCB1 Haplotypes are associated with lower P-Gp activity and major molecular plasma levels in chronic myeloid leukemia patients. Blood. 2013 ; 122( 21):[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
ABCB1 haplotype is associated with alterations in functional activity of P-GP and affects major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib (2013)
Vivona, Douglas; Lima, L; Rodrigues, Alice Cristina ; Bueno, Carolina Tosin; Chauffaille, Maria de Lourdes Lopes Ferrari; Chiattone, Carlos Sérgio; Hungria, Vania Tietsche de Moraes; Guerra-Shinohara, Elvira Maria
Fonte: Haematologica. Nome do evento: Congress of the European Hematology Association. Unidades: ICB, FCF
Assuntos: LEUCEMIA MIELOIDE, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCB1 haplotype is associated with alterations in functional activity of P-GP and affects major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Haematologica. Pavia: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2013
APA
Vivona, D., Lima, L., Rodrigues, A. C., Bueno, C. T., Chauffaille, M. de L. L. F., Chiattone, C. S., et al. (2013). ABCB1 haplotype is associated with alterations in functional activity of P-GP and affects major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Haematologica. Pavia: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Vivona D, Lima L, Rodrigues AC, Bueno CT, Chauffaille M de LLF, Chiattone CS, Hungria VT de M, Guerra-Shinohara EM. ABCB1 haplotype is associated with alterations in functional activity of P-GP and affects major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Haematologica. 2013 ; 98 404 res. P978.[citado 2024 nov. 18 ]
Vancouver
Vivona D, Lima L, Rodrigues AC, Bueno CT, Chauffaille M de LLF, Chiattone CS, Hungria VT de M, Guerra-Shinohara EM. ABCB1 haplotype is associated with alterations in functional activity of P-GP and affects major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Haematologica. 2013 ; 98 404 res. P978.[citado 2024 nov. 18 ]
Trabalho de evento-resumo
ABCB1 haplotypes are associated with lower P-Gp activity and major molecular response but do not affect imatinib plasma levels in chronic myeloid leukemia patients (2013)
Vivona, Douglas; Lima, Luciene Terezina de; Rodrigues, Alice Cristina ; Bueno, Carolina Tosin; Galtani, Cristiane M; Chiattone, Carlos Sérgio; Hungria, Vania Tietsche de Moraes; Chauffaille, Maria de Lourdes Lopes Ferrari; Guerra-Shinohara, Elvira Maria
Fonte: Abstracts. Nome do evento: American Society of Hematology Annual Meeting and Exposition. Unidades: ICB, FCF
Assuntos: LEUCEMIA MIELOIDE, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCB1 haplotypes are associated with lower P-Gp activity and major molecular response but do not affect imatinib plasma levels in chronic myeloid leukemia patients. 2013, Anais.. Oxford: american Society of Hematology, 2013. . Acesso em: 18 nov. 2024.
APA
Vivona, D., Lima, L. T. de, Rodrigues, A. C., Bueno, C. T., Galtani, C. M., Chiattone, C. S., et al. (2013). ABCB1 haplotypes are associated with lower P-Gp activity and major molecular response but do not affect imatinib plasma levels in chronic myeloid leukemia patients. In Abstracts. Oxford: american Society of Hematology.
NLM
Vivona D, Lima LT de, Rodrigues AC, Bueno CT, Galtani CM, Chiattone CS, Hungria VT de M, Chauffaille M de LLF, Guerra-Shinohara EM. ABCB1 haplotypes are associated with lower P-Gp activity and major molecular response but do not affect imatinib plasma levels in chronic myeloid leukemia patients. Abstracts. 2013 ;[citado 2024 nov. 18 ]
Vancouver
Vivona D, Lima LT de, Rodrigues AC, Bueno CT, Galtani CM, Chiattone CS, Hungria VT de M, Chauffaille M de LLF, Guerra-Shinohara EM. ABCB1 haplotypes are associated with lower P-Gp activity and major molecular response but do not affect imatinib plasma levels in chronic myeloid leukemia patients. Abstracts. 2013 ;[citado 2024 nov. 18 ]
Trabalho de evento-resumo
Polymorphisms in ABC transporter genes are associated with complete molecular response to imatinib in chronic myeloid leukemia patients (2012)
Vivona, Douglas; Lima, Luciene Terezinha de; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Fonte: Abstracts. Nome do evento: Congress of the European Hematology Association. Unidade: FCF
Assuntos: LEUCEMIA MIELOIDE, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. Polymorphisms in ABC transporter genes are associated with complete molecular response to imatinib in chronic myeloid leukemia patients. 2012, Anais.. The Hague: European Hematology Association, 2012. . Acesso em: 18 nov. 2024.
APA
Vivona, D., Lima, L. T. de, Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2012). Polymorphisms in ABC transporter genes are associated with complete molecular response to imatinib in chronic myeloid leukemia patients. In Abstracts. The Hague: European Hematology Association.
NLM
Vivona D, Lima LT de, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Polymorphisms in ABC transporter genes are associated with complete molecular response to imatinib in chronic myeloid leukemia patients. Abstracts. 2012 ;[citado 2024 nov. 18 ]
Vancouver
Vivona D, Lima LT de, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Polymorphisms in ABC transporter genes are associated with complete molecular response to imatinib in chronic myeloid leukemia patients. Abstracts. 2012 ;[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients (2012)
Boacnin, Marina do Rosário; Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Vivona, Douglas; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Ducati, André; Zanichelli, Luchessi Maria Aparecida; Chittone, Carlos Sergio; Guerra-Shinohara, Elvira Maria
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Assuntos: POLIMORFISMO, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOACNIN, Marina do Rosário et al. Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2012
APA
Boacnin, M. do R., Bueno, C. T., Lima, L. T. de, Vivona, D., Hirata, R. D. C., Hirata, M. H., et al. (2012). Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Boacnin M do R, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Ducati A, Zanichelli LMA, Chittone CS, Guerra-Shinohara EM. Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 88 res. FCF172.[citado 2024 nov. 18 ]
Vancouver
Boacnin M do R, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Ducati A, Zanichelli LMA, Chittone CS, Guerra-Shinohara EM. Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 88 res. FCF172.[citado 2024 nov. 18 ]
Artigo de periodico
ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib (2012)
Vivona, Douglas; Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Fonte: Blood Cells, Molecules, and Diseases. Unidade: FCF
Assuntos: LEUCEMIA MIELOIDE AGUDA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Blood Cells, Molecules, and Diseases, v. 48, n. 2, p. 132-136, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2011.11.001. Acesso em: 18 nov. 2024.
APA
Vivona, D., Bueno, C. T., Lima, L. T. de, Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2012). ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Blood Cells, Molecules, and Diseases, 48( 2), 132-136. doi:10.1016/j.bcmd.2011.11.001
NLM
Vivona D, Bueno CT, Lima LT de, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib [Internet]. Blood Cells, Molecules, and Diseases. 2012 ; 48( 2): 132-136.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.bcmd.2011.11.001
Vancouver
Vivona D, Bueno CT, Lima LT de, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib [Internet]. Blood Cells, Molecules, and Diseases. 2012 ; 48( 2): 132-136.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.bcmd.2011.11.001
Trabalho de evento-resumo
SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients (2011)
Guerra-Shinohara, Elvira Maria ; Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Vivona, Douglas; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Chiattone, Carlos Sérgio; Zanichelli, Maria Aparecida
Fonte: Abstracts. Nome do evento: Annual Congress of the European Hematology Association (EHA). Unidade: FCF
Assuntos: POLIMORFISMO, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA-SHINOHARA, Elvira Maria et al. SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. 2011, Anais.. Hague: European Hematology Association (EHA), 2011. . Acesso em: 18 nov. 2024.
APA
Guerra-Shinohara, E. M., Bueno, C. T., Lima, L. T. de, Vivona, D., Hirata, R. D. C., Hirata, M. H., et al. (2011). SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. In Abstracts. Hague: European Hematology Association (EHA).
NLM
Guerra-Shinohara EM, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Luchessi AD, Chiattone CS, Zanichelli MA. SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. Abstracts. 2011 ;[citado 2024 nov. 18 ]
Vancouver
Guerra-Shinohara EM, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Luchessi AD, Chiattone CS, Zanichelli MA. SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. Abstracts. 2011 ;[citado 2024 nov. 18 ]
Trabalho de evento-resumo
Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib (2011)
Guerra-Shinohara, Elvira Maria ; Vivona, Douglas; Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio
Fonte: Abstracts. Nome do evento: Annual Congress of the European Hematology Association (EHA). Unidade: FCF
Assuntos: POLIMORFISMO, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA-SHINOHARA, Elvira Maria et al. Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. 2011, Anais.. Hague: European Hematology Association (EHA), 2011. . Acesso em: 18 nov. 2024.
APA
Guerra-Shinohara, E. M., Vivona, D., Bueno, C. T., Lima, L. T. de, Hirata, R. D. C., Hirata, M. H., et al. (2011). Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. In Abstracts. Hague: European Hematology Association (EHA).
NLM
Guerra-Shinohara EM, Vivona D, Bueno CT, Lima LT de, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS. Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Abstracts. 2011 ;[citado 2024 nov. 18 ]
Vancouver
Guerra-Shinohara EM, Vivona D, Bueno CT, Lima LT de, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS. Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Abstracts. 2011 ;[citado 2024 nov. 18 ]
Trabalho de evento-resumo
Frequency of C848T, C859G, C480G and A1222G polymorphisms in SLC22A1 gene in chronic myelogenous leukaemia patients treated with imatinib mesilate (2011)
Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Vivona, Douglas; Guerra-Shinohara, Elvira Maria
Fonte: Resumos. Nome do evento: Simpósio Internacional de Iniciação Científica da Universidade de São Paulo (SIICUSP). Unidade: FCF
Assuntos: POLIMORFISMO, LEUCEMIA MIELOIDE AGUDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Carolina Tosin et al. Frequency of C848T, C859G, C480G and A1222G polymorphisms in SLC22A1 gene in chronic myelogenous leukaemia patients treated with imatinib mesilate. 2011, Anais.. São Paulo: USP/Pró-Reitoria de Pesquisa, 2011. Disponível em: https://sistemas.usp.br/siicusp/cdOnlineTrabalhoVisualizarResumo?numeroInscricaoTrabalho=2408&numeroEdicao=19. Acesso em: 18 nov. 2024.
APA
Bueno, C. T., Lima, L. T. de, Vivona, D., & Guerra-Shinohara, E. M. (2011). Frequency of C848T, C859G, C480G and A1222G polymorphisms in SLC22A1 gene in chronic myelogenous leukaemia patients treated with imatinib mesilate. In Resumos. São Paulo: USP/Pró-Reitoria de Pesquisa. Recuperado de https://sistemas.usp.br/siicusp/cdOnlineTrabalhoVisualizarResumo?numeroInscricaoTrabalho=2408&numeroEdicao=19
NLM
Bueno CT, Lima LT de, Vivona D, Guerra-Shinohara EM. Frequency of C848T, C859G, C480G and A1222G polymorphisms in SLC22A1 gene in chronic myelogenous leukaemia patients treated with imatinib mesilate [Internet]. Resumos. 2011 ;[citado 2024 nov. 18 ] Available from: https://sistemas.usp.br/siicusp/cdOnlineTrabalhoVisualizarResumo?numeroInscricaoTrabalho=2408&numeroEdicao=19
Vancouver
Bueno CT, Lima LT de, Vivona D, Guerra-Shinohara EM. Frequency of C848T, C859G, C480G and A1222G polymorphisms in SLC22A1 gene in chronic myelogenous leukaemia patients treated with imatinib mesilate [Internet]. Resumos. 2011 ;[citado 2024 nov. 18 ] Available from: https://sistemas.usp.br/siicusp/cdOnlineTrabalhoVisualizarResumo?numeroInscricaoTrabalho=2408&numeroEdicao=19
Trabalho de evento-resumo periodico
ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia (2011)
Vivona, Douglas; Lima, Luciene Terezina; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Fonte: Blood. Nome do evento: Annual Meeting and Exposition of the American Society of Hematology (ASH). Unidade: FCF
Assuntos: LEUCEMIA MIELOIDE, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2011
APA
Vivona, D., Lima, L. T., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2011). ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Vivona D, Lima LT, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli M, Chiattone CS, Guerra-Shinohara EM. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. 2011 ; 118( 21): 618 res. 604.[citado 2024 nov. 18 ]
Vancouver
Vivona D, Lima LT, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli M, Chiattone CS, Guerra-Shinohara EM. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. 2011 ; 118( 21): 618 res. 604.[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia (2011)
Lima, L. T; Vivona, Douglas; Bueno, C. T; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Fonte: Revista Brasileira de Hematologia e Hemoterapia. Nome do evento: Congresso Brasileiro de Hematologia e Hemoterapia. Unidade: FCF
Assuntos: LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, L. T et al. Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2011
APA
Lima, L. T., Vivona, D., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2011). Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Lima LT, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. 2011 ; 33 144-145 res. 0340.[citado 2024 nov. 18 ]
Vancouver
Lima LT, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. 2011 ; 33 144-145 res. 0340.[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
Frequency of C848T, C859G, C480G and A1222G polymorphisms in SLC22A1 gene in chronic myelogenous leukemia patients treated with imatinib mesilate (2011)
Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Vivona, Douglas; Chiattone, Carlos Sérgio; Zanichelli, Maria Aparecida; Guerra-Shinohara, Elvira Maria
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidade: FCF
Assunto: POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Carolina Tosin et al. Frequency of C848T, C859G, C480G and A1222G polymorphisms in SLC22A1 gene in chronic myelogenous leukemia patients treated with imatinib mesilate. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2011
APA
Bueno, C. T., Lima, L. T. de, Vivona, D., Chiattone, C. S., Zanichelli, M. A., & Guerra-Shinohara, E. M. (2011). Frequency of C848T, C859G, C480G and A1222G polymorphisms in SLC22A1 gene in chronic myelogenous leukemia patients treated with imatinib mesilate. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Bueno CT, Lima LT de, Vivona D, Chiattone CS, Zanichelli MA, Guerra-Shinohara EM. Frequency of C848T, C859G, C480G and A1222G polymorphisms in SLC22A1 gene in chronic myelogenous leukemia patients treated with imatinib mesilate. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 44 res. FCF084.[citado 2024 nov. 18 ]
Vancouver
Bueno CT, Lima LT de, Vivona D, Chiattone CS, Zanichelli MA, Guerra-Shinohara EM. Frequency of C848T, C859G, C480G and A1222G polymorphisms in SLC22A1 gene in chronic myelogenous leukemia patients treated with imatinib mesilate. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 44 res. FCF084.[citado 2024 nov. 18 ]
Dissertação (Mestrado)
Avaliação da associação dos polimorfismos C1236T, C3435T e G2677T/A no gene ABCB1 a marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica (2011)
Vivona, Douglas; Guerra-Shinohara, Elvira Maria (Orientador)
Unidade: FCF
Assuntos: HEMATOLOGIA, LEUCEMIA MIELOIDE, POLIMORFISMO (ANÁLISE;AVALIAÇÃO;GENÉTICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas. Avaliação da associação dos polimorfismos C1236T, C3435T e G2677T/A no gene ABCB1 a marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica. 2011. Dissertação (Mestrado) – Universidade de São Paulo, São Paulo, 2011. Disponível em: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-12072011-103539/. Acesso em: 18 nov. 2024.
APA
Vivona, D. (2011). Avaliação da associação dos polimorfismos C1236T, C3435T e G2677T/A no gene ABCB1 a marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica (Dissertação (Mestrado). Universidade de São Paulo, São Paulo. Recuperado de http://www.teses.usp.br/teses/disponiveis/9/9136/tde-12072011-103539/
NLM
Vivona D. Avaliação da associação dos polimorfismos C1236T, C3435T e G2677T/A no gene ABCB1 a marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica [Internet]. 2011 ;[citado 2024 nov. 18 ] Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-12072011-103539/
Vancouver
Vivona D. Avaliação da associação dos polimorfismos C1236T, C3435T e G2677T/A no gene ABCB1 a marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica [Internet]. 2011 ;[citado 2024 nov. 18 ] Available from: http://www.teses.usp.br/teses/disponiveis/9/9136/tde-12072011-103539/
Trabalho de evento-resumo periodico
ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate (2011)
Lima, Luciene Terezinha de; Vivona, Douglas; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Chiattone, Carlos Sérgio; Zanichelli, Maria Aparecida; Guerra-Shinohara, Elvira Maria
Fonte: Brazilian Journal of Pharmaceutical Sciences. Nome do evento: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidade: FCF
Assuntos: LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Luciene Terezinha de et al. ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2011
APA
Lima, L. T. de, Vivona, D., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Chiattone, C. S., et al. (2011). ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Chiattone CS, Zanichelli MA, Guerra-Shinohara EM. ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 66 res. FCF128.[citado 2024 nov. 18 ]
Vancouver
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Chiattone CS, Zanichelli MA, Guerra-Shinohara EM. ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 66 res. FCF128.[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia (2011)
Vivona, Douglas; Lima, Luciene Terezina; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Fonte: Blood. Nome do evento: American Society of Hematology (ASH). Unidade: FCF
Assuntos: LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2011
APA
Vivona, D., Lima, L. T., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2011). ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Vivona D, Lima LT, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli M, Chiattone CS, Guerra-Shinohara EM. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. 2011 ; 118( 21):[citado 2024 nov. 18 ]
Vancouver
Vivona D, Lima LT, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli M, Chiattone CS, Guerra-Shinohara EM. ABCG2 and SLC22A1 expression are associated with imatinib response in chronic myeloid leukemia. Blood. 2011 ; 118( 21):[citado 2024 nov. 18 ]

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Nome do evento

País de publicação

Indexado em

Afiliação dos autores externos não normalizada